Biostatistics of VHL-Gene Transfection in the Health Informatics Analysis of Renal Cell Carcinoma
- PMID: 35035522
- PMCID: PMC8759873
- DOI: 10.1155/2022/5297580
Biostatistics of VHL-Gene Transfection in the Health Informatics Analysis of Renal Cell Carcinoma
Abstract
Objective: In this paper, we study the role of the VHL gene in regulating the proliferation and apoptosis of renal cell carcinoma, as well as the safety and transfection efficiency of ultrasound microbubble gene transfection technology.
Method: We use kidney cancer cell lines as an in vitro research object and apply ultrasound microbubble gene transfection technology to transfect the VHL gene into kidney cancer cell line (786-0). The proliferation and apoptosis of cells were measured to clarify the inhibitory effect of the VHL gene in renal cell carcinoma. After that, pEGFP-VHL was transfected using ultrasonic microbubble and liposome gene transfection techniques, respectively, and the transfection efficiency was measured by immunofluorescence.
Results: Compared with untreated and 786-0 cells that are transfected with empty vector, the expression level of VHL gene mRNA in 786-0 cells that are transfected with pcDNA3.1-VHL was significantly increased, and the cell growth inhibition rate was significantly higher. The rate of apoptosis increased significantly. Transfection efficiency of the pEGFP-VHL gene after transfection of 786-0 cells for 48 h: control group 0, liposome group (35.55 ± 2.77) %, ultrasound microbubble group (18.27 ± 2.83) %, and two transfection methods on cells. There is no significant difference in the impact of vitality.
Conclusion: VHL gene expression can significantly inhibit the proliferation ability of renal cancer cell line 786-0 and promote its apoptosis. VHL gene is a potential target for gene therapy of kidney cancer.
Copyright © 2022 Yunxiang Gong et al.
Conflict of interest statement
The authors declare that they have no conflicts of interest.
Figures






Similar articles
-
MicroRNA-185 inhibits cell proliferation and induces cell apoptosis by targeting VEGFA directly in von Hippel-Lindau-inactivated clear cell renal cell carcinoma.Urol Oncol. 2015 Apr;33(4):169.e1-11. doi: 10.1016/j.urolonc.2015.01.003. Epub 2015 Feb 17. Urol Oncol. 2015. PMID: 25700976
-
Suppression of growth of renal carcinoma cells by the von Hippel-Lindau tumor suppressor gene.Cancer Res. 1995 Nov 1;55(21):4804-7. Cancer Res. 1995. PMID: 7585510
-
Mutations of the von Hippel-Lindau gene confer increased susceptibility to natural killer cells of clear-cell renal cell carcinoma.Oncogene. 2011 Jun 9;30(23):2622-32. doi: 10.1038/onc.2010.638. Epub 2011 Jan 24. Oncogene. 2011. PMID: 21258414
-
[Tumor suppressor gene VHL, hypoxia inducible factor, and renal cell carcinoma].Zhonghua Bing Li Xue Za Zhi. 2006 Sep;35(9):562-4. Zhonghua Bing Li Xue Za Zhi. 2006. PMID: 17134554 Review. Chinese. No abstract available.
-
The von Hippel-Lindau tumor suppressor protein and clear cell renal carcinoma.Clin Cancer Res. 2007 Jan 15;13(2 Pt 2):680s-684s. doi: 10.1158/1078-0432.CCR-06-1865. Clin Cancer Res. 2007. PMID: 17255293 Review.
Cited by
-
An inflammation-related signature could predict the prognosis of patients with kidney renal clear cell carcinoma.Front Genet. 2022 Aug 11;13:866696. doi: 10.3389/fgene.2022.866696. eCollection 2022. Front Genet. 2022. PMID: 36035192 Free PMC article.
References
-
- Latif F. Disease tumor suppressor gene. Science . 1993;260:1317–1320. - PubMed
-
- Kim M., Yan Y., Lee K., Sgagias M., Cowan K. H. Ectopic expression of von Hippel-Lindau tumor suppressor induces apoptosis in 786-O renal cell carcinoma cells and regresses tumor growth of 786-O cells in nude mouse. Biochemical and Biophysical Research Communications . 2004;320(3):945–950. doi: 10.1016/j.bbrc.2004.06.042. - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical